Advertisement

Topics

FDA committee to review Pfizer's psoriatic arthritis drug

05:32 EDT 3 Aug 2017 | SmartBrief

Pfizer's supplemental new drug applications for Xeljanz, or tofacitinib, indicated for treatment of adults with active psori -More

Original Article: FDA committee to review Pfizer's psoriatic arthritis drug

NEXT ARTICLE

More From BioPortfolio on "FDA committee to review Pfizer's psoriatic arthritis drug"

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...